共 236 条
[1]
Parsons DW(2008)An integrated genomic analysis of human glioblastoma multiforme Science 321 1807-12
[2]
Jones S(2009)IDH1 and IDH2 mutations in gliomas N Engl J Med 360 765-773
[3]
Zhang X(2013)IDH1 and IDH2 mutations in gliomas Curr Neurol Neurosci Rep 13 345-9
[4]
Lin JC(2013)Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution Mod Pathol 26 922-251
[5]
Leary RJ(2015)Prognostic significance of relative 1p/19q codeletion in oligodendroglial tumors J Neuro Oncol 125 249-820
[6]
Angenendt P(2016)The 2016 World Health Organization classification of tumors of the central nervous system: a summary Acta Neuropathol 131 803-290
[7]
Mankoo P(2016)Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma Neuro Oncology 18 283-205
[8]
Carter H(2012)Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy J Neuro Oncol 107 197-3663
[9]
Siu IM(2013)Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate J Clin Investig 123 3659-150
[10]
Gallia GL(2015)Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging J Neuro Oncol 121 141-65